CNBG vaccine with 86% efficacy registered in Bahrain

Source: Global Times Published: 2020/12/13 16:14:48

Photo: CNBG

Bahraini government has registered a COVID-19 vaccine developed by Chinese producer CNBG after reviewing its phase 3 clinical trial data that shows 86% efficacy rate, and 100% efficacy in preventing medium and severe symptoms.

Posted in: SOCIETY

blog comments powered by Disqus